BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

36 related articles for article (PubMed ID: 11745874)

  • 21. Immunohistochemical expression of p53 proteins in Wilms' tumour: a possible association with the histological prognostic parameter of anaplasia.
    Cheah PL; Looi LM; Chan LL
    Histopathology; 1996 Jan; 28(1):49-54. PubMed ID: 8838120
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical detection of p53 protein expression as a prognostic factor in Wilms tumor.
    Jadali F; Sayadpour D; Rakhshan M; Karimi A; Rouzrokh M; Shamsian BS; Shamshiri AR
    Iran J Kidney Dis; 2011 Jul; 5(3):149-53. PubMed ID: 21525573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunohistochemical detection of p53 in Wilms' tumors correlates with unfavorable outcome.
    Lahoti C; Thorner P; Malkin D; Yeger H
    Am J Pathol; 1996 May; 148(5):1577-89. PubMed ID: 8623926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p53 Immunohistochemistry expression in Wilms tumor: a prognostic tool in the detection of tumor aggressiveness.
    Franken J; Lerut E; Van Poppel H; Bogaert G
    J Urol; 2013 Feb; 189(2):664-70. PubMed ID: 23036984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. p53 expression in Wilms' tumor: a possible role as prognostic factor.
    Beniers AJ; Efferth T; Füzesi L; Granzen B; Mertens R; Jakse G
    Int J Oncol; 2001 Jan; 18(1):133-9. PubMed ID: 11115550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical detection of p53 protein expression as a prognostic indicator in Wilms tumor.
    Sredni ST; de Camargo B; Lopes LF; Teixeira R; Simpson A
    Med Pediatr Oncol; 2001 Nov; 37(5):455-8. PubMed ID: 11745874
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
    Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
    Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histological analysis of aggressiveness and responsiveness in Wilms' tumor.
    Beckwith JB; Zuppan CE; Browning NG; Moksness J; Breslow NE
    Med Pediatr Oncol; 1996 Nov; 27(5):422-8. PubMed ID: 8827069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Focal versus diffuse anaplasia in Wilms tumor--new definitions with prognostic significance: a report from the National Wilms Tumor Study Group.
    Faria P; Beckwith JB; Mishra K; Zuppan C; Weeks DA; Breslow N; Green DM
    Am J Surg Pathol; 1996 Aug; 20(8):909-20. PubMed ID: 8712292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intra-tumor genetic heterogeneity in Wilms tumor samples.
    de Sá Pereira BM; Azevedo RM; Aguirre Neto JC; Menezes CF; Rodrigues KE; Faria PA; Camargo B; Maschietto M
    Rev Assoc Med Bras (1992); 2019 Dec; 65(12):1496-1501. PubMed ID: 31994632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New developments in the pathology of Wilms tumor.
    Beckwith JB
    Cancer Invest; 1997; 15(2):153-62. PubMed ID: 9095211
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 35.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.